Sound Coding Strategies for Hearing Loss
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Cochlear Implant, Bionic Ear, Auditory Prosthesis, Electric-only Spectral Resolution, Modulation Detection Threshold (MDT) and Gap Detection Tasks, Single-Electrode Pulse Train, Sound Coding Strategy?
Research shows that new sound coding strategies for cochlear implants, like the FOF1F2 and SCORE, improve speech understanding, especially in noisy environments and at low sound levels. These strategies help users recognize more words correctly and enhance speech intelligibility by better encoding sound loudness.12345
Is the sound coding strategy for hearing loss generally safe for humans?
How is the cochlear implant treatment unique for hearing loss?
Cochlear implants use advanced sound coding strategies, like the SCORE and eTone, to improve speech perception by enhancing pitch and loudness information, which is not possible with traditional hearing aids. These strategies help users better understand speech in noisy environments and improve music perception by accurately encoding sound frequencies.1251112
What is the purpose of this trial?
The purpose of this study is to understand performance with a cochlear implant. The long-term goals of this research are to improve sound perception with cochlear implants and to better understand the functioning of the auditory system. Information from individuals with and without cochlear implants will be compared.
Research Team
David M Landsberger, MD
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for children and adults with cochlear implants implanted before age 2, those who have some hearing left with aids, or normal hearing. It's open to ages 7-35 if pre-lingually implanted and 18+ for post-lingual implantation or normal hearing. Post-lingually implanted children cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment of participants' auditory performance and psychophysical abilities
Treatment
Participants undergo manipulations in cochlear implant coding strategies to improve psychophysical and speech recognition outcomes
Follow-up
Participants are monitored for changes in auditory performance and psychophysical abilities after treatment
Treatment Details
Interventions
- Cochlear Implant
- Electric-only Spectral Resolution
- Modulation Detection Threshold (MDT) and Gap Detection Tasks
- Single-Electrode Pulse Train
- Sound Coding Strategy
Cochlear Implant is already approved in United States, European Union for the following indications:
- Single-sided deafness (SSD) in children aged 5 years and older
- Severe to profound sensorineural hearing loss in both ears
- Severe to profound sensorineural hearing loss in both ears
- Single-sided deafness (SSD) in children and adults
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor